{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:44:37Z","timestamp":1760035477788,"version":"build-2065373602"},"reference-count":36,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T00:00:00Z","timestamp":1752192000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: The nephrotic syndrome (NS) is the most common acquired childhood kidney disease. Steroids represent the cornerstone of the therapeutic strategy, representing the first-line approach, but optimal therapeutic management is debated. This study aimed to compare different steroid therapeutic management protocols. Patients and Methods: A total of 140 NS pediatric patients were enrolled retrospectively. All the kids were divided among three different groups according to the three different steroid therapeutic schemes: 2240 mg\/m2 (group 1), 3360 mg\/m2 (group 2), or 3640 mg\/m2 (group 3) and divided in frequently relapsing (FR-NS) or steroid-dependent (SD) NS. Results: Within group 1, 50% of the population developed FR-NS; 100% of those kids were between 2 and 6 years old. Within the second group, 54% of the patients developed FR-NS, and 83% of these kids were between 2 and 6 years old, i.e., 45% of the group population. Within group 3, 45% of the patients developed FR-NS, and 70% of these kids were among 2 and 6 years old, i.e., 32% of the group population. This group exhibits the lowest percentage (42%) of patients in the highest relapse category (\u22655 relapses) compared to the other protocols, indicating that this protocol might be more effective at reducing the number of frequent relapses. No specific predictor factors of FR- or SD-NS were revealed in the studied cohort. Conclusions: A longer steroid scheme does not correlate with a better outcome, nor does it reduce the number of relapses or prevent steroid failure.<\/jats:p>","DOI":"10.3390\/medicina61071257","type":"journal-article","created":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T08:15:47Z","timestamp":1752221747000},"page":"1257","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Management of Nephrotic Syndrome in Pediatric Patients Treated by Different Steroid Regimens"],"prefix":"10.3390","volume":"61","author":[{"given":"Valeria","family":"Chirico","sequence":"first","affiliation":[{"name":"Pediatric Nephrology and Dialysis Unit, University Hospital \u201cG. Martino\u201d, 98124 Messina, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filippo","family":"Tripodi","sequence":"additional","affiliation":[{"name":"Pediatric Nephrology and Dialysis Unit, University Hospital \u201cG. Martino\u201d, 98124 Messina, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0617-500X","authenticated-orcid":false,"given":"Giovanni","family":"Conti","sequence":"additional","affiliation":[{"name":"Pediatric Nephrology and Dialysis Unit, University Hospital \u201cG. Martino\u201d, 98124 Messina, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorena","family":"Silipigni","sequence":"additional","affiliation":[{"name":"Pediatric Nephrology and Dialysis Unit, University Hospital \u201cG. Martino\u201d, 98124 Messina, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1705-8770","authenticated-orcid":false,"given":"Antonio","family":"Lacquaniti","sequence":"additional","affiliation":[{"name":"Nephrology and Dialysis Unit, Papardo Hospital, 98124 Messina, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0492-5022","authenticated-orcid":false,"given":"Paolo","family":"Monardo","sequence":"additional","affiliation":[{"name":"Nephrology and Dialysis Unit, Papardo Hospital, 98124 Messina, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9143-4637","authenticated-orcid":false,"given":"Roberto","family":"Chimenz","sequence":"additional","affiliation":[{"name":"Pediatric Nephrology and Dialysis Unit, University Hospital \u201cG. Martino\u201d, 98124 Messina, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,7,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0140-6736(18)30536-1","article-title":"Idiopathic nephrotic syndrome in children","volume":"392","author":"Noone","year":"2018","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(03)14184-0","article-title":"Nephrotic syndrome in childhood","volume":"362","author":"Eddy","year":"2003","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s00467-022-05739-3","article-title":"IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome","volume":"38","author":"Trautmann","year":"2023","journal-title":"Pediatr. Nephrol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2215\/CJN.05000516","article-title":"Minimal Change Disease","volume":"12","author":"Vivarelli","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1080\/20469047.2017.1374003","article-title":"Nephrotic syndrome in infants and children: Pathophysiology and management","volume":"37","author":"Downie","year":"2017","journal-title":"Paediatr. Int. Child. Health"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1053\/j.akdh.2024.02.002","article-title":"Minimal Change Disease","volume":"31","author":"Gomez","year":"2024","journal-title":"Adv. Kidney Dis. Health"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s00467-013-2567-8","article-title":"The nephrotic syndrome: Pathogenesis and treatment of edema formation and secondary complications","volume":"29","author":"Cadnapaphornchai","year":"2014","journal-title":"Pediatr. Nephrol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1093\/ndt\/gfac314","article-title":"Steroid-sensitive nephrotic syndrome in children","volume":"38","author":"Boyer","year":"2023","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1007\/s00467-020-04519-1","article-title":"IPNA clinical practice recommendations for the diagnosis and management of children with steroid-resistant nephrotic syndrome","volume":"35","author":"Trautmann","year":"2020","journal-title":"Pediatr. Nephrol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.2215\/CJN.05200422","article-title":"How I Treat Steroid-Sensitive Nephrotic Syndrome in Children","volume":"17","author":"Vivarelli","year":"2022","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1007\/s00431-021-04035-w","article-title":"Steroid treatment for the first episode of childhood nephrotic syndrome: Comparison of the 8- and 12-weeks regimen using an individual patient data meta-analysis","volume":"180","author":"Schijvens","year":"2021","journal-title":"Eur. J. Pediatr."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Pal, A., and Kaskel, F. (2016). History of Nephrotic Syndrome and Evolution of its Treatment. Front. Pediatr., 4.","DOI":"10.3389\/fped.2016.00056"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13052-017-0356-x","article-title":"The Italian Society for Pediatric Nephrology (SINePe) consensus document on the management of nephrotic syndrome in children: Part I\u2014Diagnosis and treatment of the first episode and the first relapse","volume":"43","author":"Pasini","year":"2017","journal-title":"Ital. J. Pediatr."},{"key":"ref_14","unstructured":"(1979). Nephrotic syndrome in children: A randomized trial comparing two prednisone regimens in steroid-responsive patients who relapse early. Report of the international study of kidney disease in children. J. Pediatr., 95, 239\u2013243."},{"key":"ref_15","first-page":"CD001533","article-title":"Corticosteroid therapy for nephrotic syndrome in children","volume":"2020","author":"Hodson","year":"2000","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","article-title":"Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members. Evaluation and management of chronic kidney disease: Synopsis of the kidney disease: Improving global outcomes 2012 clinical practice guideline","volume":"158","author":"Stevens","year":"2013","journal-title":"Ann. Intern. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00467-012-2304-8","article-title":"Kidney Disease: Improving Global Outcomes. Treatment of steroid-resistant nephrotic syndrome in children: New guidelines from KDIGO","volume":"28","author":"Lombel","year":"2013","journal-title":"Pediatr. Nephrol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1681\/ASN.2012070646","article-title":"Extending prednisolone treatment does not reduce relapses in childhood nephrotic syndrome","volume":"24","author":"Teeninga","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_19","first-page":"CD001533","article-title":"Corticosteroid therapy for nephrotic syndrome in children","volume":"2015","author":"Hahn","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_20","first-page":"CD001533","article-title":"Corticosteroid therapy for nephrotic syndrome in children","volume":"8","author":"Hahn","year":"2024","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00467-021-04983-3","article-title":"Update on the treatment of steroid-sensitive nephrotic syndrome","volume":"37","author":"Zotta","year":"2022","journal-title":"Pediatr. Nephrol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s00467-008-1089-2","article-title":"Prednisone dosing per body weight or body surface area in children with nephrotic syndrome: Is it equivalent?","volume":"24","author":"Feber","year":"2009","journal-title":"Pediatr. Nephrol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00467-018-4127-8","article-title":"Equations to estimate prednisone dose using body weight","volume":"34","author":"Emma","year":"2019","journal-title":"Pediatr. Nephrol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00467-014-2903-7","article-title":"Best practice guidelines for idiopathic nephrotic syndrome: Recommendations versus reality","volume":"30","author":"Pasini","year":"2015","journal-title":"Pediatr. Nephrol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/s00467-022-05702-2","article-title":"Relapse rate in children with nephrotic syndrome during the SARS-CoV-2 pandemic","volume":"38","author":"Chiodini","year":"2023","journal-title":"Pediatr. Nephrol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1007\/s00467-022-05824-7","article-title":"Treatment of idiopathic nephrotic syndrome at onset: A comparison between 8- and 12-week regimens in everyday clinical practice","volume":"38","author":"Lucchetti","year":"2023","journal-title":"Pediatr. Nephrol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ekir.2019.12.015","article-title":"Prediction of Short- and Long-Term Outcomes in Childhood Nephrotic Syndrome","volume":"5","author":"Carter","year":"2019","journal-title":"Kidney Int. Rep."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s00467-013-2736-9","article-title":"Predictors of remission and relapse in idiopathic nephrotic syndrome: A prospective cohort study","volume":"29","author":"Sureshkumar","year":"2014","journal-title":"Pediatr. Nephrol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1007\/s004670100683","article-title":"Prediction of subsequent relapse in children with steroid-sensitive nephrotic syndrome","volume":"16","author":"Takeda","year":"2001","journal-title":"Pediatr. Nephrol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"l1800","DOI":"10.1136\/bmj.l1800","article-title":"Long term tapering versus standard prednisolone treatment for first episode of childhood nephrotic syndrome: Phase III randomised controlled trial and economic evaluation","volume":"365","author":"Webb","year":"2019","journal-title":"BMJ"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s00467-010-1537-7","article-title":"Early age at debut is a predictor of steroid-dependent and frequent relapsing nephrotic syndrome","volume":"25","author":"Andersen","year":"2010","journal-title":"Pediatr. Nephrol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s004670100024","article-title":"Risk factors for steroid dependency in children with idiopathic nephrotic syndrome","volume":"16","author":"Yap","year":"2001","journal-title":"Pediatr. Nephrol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0140-6736(23)01051-6","article-title":"Childhood nephrotic syndrome","volume":"402","author":"Vivarelli","year":"2023","journal-title":"Lancet"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.kint.2024.11.006","article-title":"Executive summary of the KDIGO 2025 Clinical Practice Guideline for the Management of Nephrotic Syndrome in Children","volume":"107","author":"Floege","year":"2025","journal-title":"Kidney Int."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.2215\/CJN.07180622","article-title":"The immune system and idiopathic nephrotic syndrome","volume":"17","author":"Campbell","year":"2022","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1056\/NEJM199008303230905","article-title":"Abnormalities of lipoprotein metabolism in patients with the nephrotic syndrome","volume":"323","author":"Joven","year":"1990","journal-title":"N. Engl. J. Med."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/7\/1257\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:08:20Z","timestamp":1760033300000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/7\/1257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,11]]},"references-count":36,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["medicina61071257"],"URL":"https:\/\/doi.org\/10.3390\/medicina61071257","relation":{},"ISSN":["1648-9144"],"issn-type":[{"type":"electronic","value":"1648-9144"}],"subject":[],"published":{"date-parts":[[2025,7,11]]}}}